In the latest trading session, 0.45 million TELA Bio Inc (NASDAQ:TELA) shares changed hands as the company’s beta touched 0.99. With the company’s most recent per share price at $2.78 changing hands around $0.29 or 11.45% at last look, the market valuation stands at $68.57M. TELA’s current price is a discount, trading about -182.01% off its 52-week high of $7.84. The share price had its 52-week low at $2.30, which suggests the last value was 17.27% up since then. When we look at TELA Bio Inc’s average trading volume, we note the 10-day average is 50740.0 shares, with the 3-month average coming to 165.52K.
Analysts gave the TELA Bio Inc (TELA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TELA as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. TELA Bio Inc’s EPS for the current quarter is expected to be -0.41.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
TELA Bio Inc (NASDAQ:TELA) trade information
Instantly TELA is in green as seen in intraday trades today. With action 6.73%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -58.08%, with the 5-day performance at 6.73% in the green. However, in the 30-day time frame, TELA Bio Inc (NASDAQ:TELA) is 19.61% up. Looking at the short shares, we see there were 1.64 million shares sold at short interest cover period of 9.63 days.
The consensus price target for the stock as assigned by Wall Street analysts is 11, meaning bulls need an upside of 74.73% from its recent market value. According to analyst projections, TELA’s forecast low is 8 with 20 as the target high. To hit the forecast high, the stock’s price needs a -619.42% plunge from its current level, while the stock would need to soar -187.77% for it to hit the projected low.
TELA Bio Inc (TELA) estimates and forecasts
Data shows that the TELA Bio Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -37.64% over the past 6 months, a 31.37% in annual growth rate that is considerably higher than the industry average of 17.40%. Year-over-year growth is forecast to reach 27.30% up from the last financial year.
Consensus estimates given by 5 financial analysts project the company’s revenue in the current quarter to hit an average of 18.75M. 5 analysts are of the opinion that TELA Bio Inc’s revenue for the current quarter will be 22.95M. The company’s revenue for the corresponding quarters a year ago was 15.05M and 17M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 24.60%. The estimates for the next quarter sales put growth at 35.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 5.17%. The 2024 estimates are for TELA Bio Inc earnings to increase by 28.13%.
TELA Dividends
TELA Bio Inc is expected to release its next quarterly earnings report on 2024-Nov-07.
TELA Bio Inc (NASDAQ:TELA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 7.16% of TELA Bio Inc shares while 85.63% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 92.23%. There are 85.63% institutions holding the TELA Bio Inc stock share, with ESSEX WOODLANDS MANAGEMENT, INC. the top institutional holder. As of 2024-06-30, the company held 16.7242% of the shares, roughly 4.11 million TELA shares worth $19.32 million.
ORBIMED ADVISORS LLC holds the second largest percentage of outstanding shares, with 9.9984% or 2.46 million shares worth $11.55 million as of 2024-06-30.
